CLINICAL_TRIALS
trial_result
· 2011-07-12
Clinical Trial Update: Preemptive Strike With Bortezomib in Multiple Myeloma Patients [Phase 3]
Summary
A Phase 3 trial evaluating preemptive treatment with bortezomib in multiple myeloma was terminated, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 3 | Status: TERMINATED | Results posted: 2011-07-12